Clinical Trials for the week of August 21

August 19, 2024 Clinical Trials
Clinical Trials, contributed by Howard A. Young
Clinical Trials, contributed by Howard A. Young

Clinical Trials of interest to cytokine & interferon researchers

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC)
ClinicalTrials.gov ID NCT05867004
Sponsor Institut Claudius Regaud
Information provided by Institut Claudius Regaud (Responsible Party)
Last Update Posted 2023

Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV
ClinicalTrials.gov ID NCT01125228
Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by National Institutes of Health Clinical Center (CC) (National Institute of Allergy and Infectious Diseases (NIAID)) (Responsible Party)
Last Update Posted 2024-05-03

Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
ClinicalTrials.gov ID NCT04979052
Sponsor Radboud University Medical Center
Information provided by Radboud University Medical Center (Responsible Party)
Last Update Posted 2023-11-03

Related Articles

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of September 4

September 2, 2024 Clinical Trials

Pegylated Interferon Lambda for Treatment of COVID-19 Infection | Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive | Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of September 18

September 16, 2024 Clinical Trials

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE) | Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS) [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of August 7

August 1, 2024 Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]